Applied BioCode Corporation (TPE:6598)
Taiwan
· Delayed Price · Currency is TWD 19.40
+0.20 (1.04%)
May 9, 2025, 1:30 PM CST
Applied BioCode Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Revenue | 343.07 | 395.17 | 390.3 | 319.96 | 299.02 | Upgrade
|
| Revenue Growth (YoY) | -13.18% | 1.25% | 21.98% | 7.00% | 185.61% | Upgrade
|
| Cost of Revenue | 139.07 | 126.43 | 156.13 | 130.6 | 105.49 | Upgrade
|
| Gross Profit | 204 | 268.74 | 234.17 | 189.37 | 193.52 | Upgrade
|
| Selling, General & Admin | 209.05 | 209.15 | 188.04 | 148.46 | 130.03 | Upgrade
|
| Research & Development | 272.62 | 246.01 | 238.37 | 205.85 | 197.01 | Upgrade
|
| Operating Expenses | 481.91 | 455.44 | 426.77 | 354.31 | 327.04 | Upgrade
|
| Operating Income | -277.91 | -186.7 | -192.6 | -164.94 | -133.51 | Upgrade
|
| Interest Expense | -1.43 | -2.17 | -2.78 | -2.87 | -4.31 | Upgrade
|
| Interest & Investment Income | 27.63 | 23.96 | 8.51 | 3.11 | 3.73 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.35 | -0.31 | 1.22 | -0 | 3.81 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.16 | 0.01 | 0.95 | -0.46 | -1.24 | Upgrade
|
| EBT Excluding Unusual Items | -253.9 | -165.21 | -184.71 | -165.17 | -131.53 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.92 | - | -0.01 | - | Upgrade
|
| Legal Settlements | -6.88 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 28.06 | Upgrade
|
| Pretax Income | -260.78 | -163.44 | -184.71 | -165.18 | -103.47 | Upgrade
|
| Income Tax Expense | 0.03 | 0.76 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Net Income | -260.81 | -164.2 | -184.73 | -165.2 | -103.5 | Upgrade
|
| Net Income to Common | -260.81 | -164.2 | -184.73 | -165.2 | -103.5 | Upgrade
|
| Shares Outstanding (Basic) | 91 | 82 | 82 | 82 | 78 | Upgrade
|
| Shares Outstanding (Diluted) | 91 | 82 | 82 | 82 | 78 | Upgrade
|
| Shares Change (YoY) | 10.82% | 0.01% | 0.07% | 5.33% | 20.69% | Upgrade
|
| EPS (Basic) | -2.88 | -2.01 | -2.26 | -2.02 | -1.33 | Upgrade
|
| EPS (Diluted) | -2.88 | -2.01 | -2.26 | -2.02 | -1.33 | Upgrade
|
| Free Cash Flow | -215.12 | -211.48 | 123.73 | -167.29 | -174.32 | Upgrade
|
| Free Cash Flow Per Share | -2.37 | -2.59 | 1.51 | -2.05 | -2.25 | Upgrade
|
| Gross Margin | 59.46% | 68.01% | 60.00% | 59.18% | 64.72% | Upgrade
|
| Operating Margin | -81.01% | -47.25% | -49.35% | -51.55% | -44.65% | Upgrade
|
| Profit Margin | -76.02% | -41.55% | -47.33% | -51.63% | -34.61% | Upgrade
|
| Free Cash Flow Margin | -62.70% | -53.52% | 31.70% | -52.29% | -58.30% | Upgrade
|
| EBITDA | -231.33 | -139.2 | -151.85 | -128 | -104.05 | Upgrade
|
| EBITDA Margin | -67.43% | -35.23% | -38.91% | -40.01% | -34.80% | Upgrade
|
| D&A For EBITDA | 46.58 | 47.5 | 40.75 | 36.94 | 29.46 | Upgrade
|
| EBIT | -277.91 | -186.7 | -192.6 | -164.94 | -133.51 | Upgrade
|
| EBIT Margin | -81.01% | -47.25% | -49.35% | -51.55% | -44.65% | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.